Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 1.6
-5.88 %
$ 315 M
Market Cap
-2.39
P/E
ESPR - CASH & EQUIVALENTS
Cash & Equivalents ESPR - Esperion Therapeutics, Inc.
82.2 M
LAST VALUE
-37.25%
2 YEAR CAGR
17.34%
5 YEAR CAGR
3.82%
10 YEAR CAGR